Skip to main content
Top
Published in: Endocrine Pathology 2/2016

01-06-2016

A Case of Cushing’s Syndrome with Multiple Adrenocortical Adenomas Composed of Compact Cells and Clear Cells

Authors: Masahiro Asakawa, Takanobu Yoshimoto, Mitsutane Ota, Mitsuyuki Numasawa, Yuriko Sasahara, Takato Takeuchi, Yujiro Nakano, Norihiko Oohara, Masanori Murakami, Ryotaro Bouchi, Isao Minami, Kyoichiro Tsuchiya, Koshi Hashimoto, Hajime Izumiyama, Naoko Kawamura, Kazunori Kihara, Mariko Negi, Takumi Akashi, Yoshinobu Eishi, Hironobu Sasano, Yoshihiro Ogawa

Published in: Endocrine Pathology | Issue 2/2016

Login to get access

Abstract

A 58-year-old woman was referred to our hospital for Cushingoid features and diagnosed as adrenal Cushing’s syndrome due to a right adrenocortical mass (60 × 55 mm). The mass was composed of three different tumors; the first one was homogeneously lipid-poor neoplasm measuring 20 × 13 mm located at the most dorsal region, the second one was heterogeneous and lipid-rich tumor containing multiple foci of calcification measuring 50 × 32 mm located at the central region, and the last one was heterogeneous harboring dilated and tortuous vessels and lipid-poor one measuring 35 × 18 mm at the most ventral region of the adrenal gland. A right adrenalectomy was subsequently performed by open surgery. Macroscopic and microscopic analyses revealed that all three tumors were adrenocortical adenomas; the first one represents a pigmented adrenocortical adenoma, the second one adrenocortical adenoma associated with degeneration, and the third one adrenocortical adenoma harboring extensive degeneration. Immunohistochemical analysis of the steroidogenic enzymes also revealed that all of the tumors had the capacity of synthesizing cortisol. This is a very rare case of Cushing’s syndrome caused by multiple adrenocortical adenomas including a pigmented adenoma. Immunohistochemical analysis of steroidogenic enzymes contributed to understanding of steroidogenesis in each of these three different adrenocortical adenomas in this case.
Literature
1.
go back to reference Robinson MJ, Pardo V, Rywlin AM. Pigmented nodules (black adenomas) of the adrenal. An autopsy study of incidence, morphology, and function. Hum Pathol 3: 317–325, 1972CrossRefPubMed Robinson MJ, Pardo V, Rywlin AM. Pigmented nodules (black adenomas) of the adrenal. An autopsy study of incidence, morphology, and function. Hum Pathol 3: 317–325, 1972CrossRefPubMed
2.
go back to reference Suzuki K, Ojima M, Sasano N. Ultrastructure of pigment in adrenocortical pigmented adenomas of Cushing’s syndrome and in non-functioning pigmented nodules with respect to tissue steroid analyses. Virchow Arch A Pathol Anat histopathol 405: 161–173, 1985CrossRef Suzuki K, Ojima M, Sasano N. Ultrastructure of pigment in adrenocortical pigmented adenomas of Cushing’s syndrome and in non-functioning pigmented nodules with respect to tissue steroid analyses. Virchow Arch A Pathol Anat histopathol 405: 161–173, 1985CrossRef
3.
go back to reference Okura T, Miyoshi K, Watanabe S, Kurata M, Irita J, Manabe S Fukuoka T, Higaki J, Sasano H. Coexistence of three distinct adrenal tumors in the same adrenal gland in a patient with primary aldosteronism and preclinical Cushing’s syndrome. Clin Exp Nephrol 10: 127–130, 2006CrossRefPubMed Okura T, Miyoshi K, Watanabe S, Kurata M, Irita J, Manabe S Fukuoka T, Higaki J, Sasano H. Coexistence of three distinct adrenal tumors in the same adrenal gland in a patient with primary aldosteronism and preclinical Cushing’s syndrome. Clin Exp Nephrol 10: 127–130, 2006CrossRefPubMed
4.
go back to reference Armand R, Cappola AR, Horenstein RB, Drachenberg CB, Sasano H, Papadimitriou JC. Adrenal cortical adenoma with excess black pigment deposition, combined with myelolipoma and clinical Cushing’s syndrome. Int J Surg Pathol 12(1): 57–61, 2004CrossRefPubMed Armand R, Cappola AR, Horenstein RB, Drachenberg CB, Sasano H, Papadimitriou JC. Adrenal cortical adenoma with excess black pigment deposition, combined with myelolipoma and clinical Cushing’s syndrome. Int J Surg Pathol 12(1): 57–61, 2004CrossRefPubMed
5.
go back to reference Sasano H. Localization of steroidogenic enzymes in adrenal cortex and its disorders. Endocrine Journal 41(5): 471–482, 1994CrossRefPubMed Sasano H. Localization of steroidogenic enzymes in adrenal cortex and its disorders. Endocrine Journal 41(5): 471–482, 1994CrossRefPubMed
6.
go back to reference Gomez-Sanchez CE, Qi X, Velarde-Miranda C, Plonczynski MW, Parker CR, Rainey W, Satoh F, Maekawa T, Nakamura Y, Sasano H, Gomez-Sanchez EP. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol 383: 111–117, 2014CrossRefPubMedPubMedCentral Gomez-Sanchez CE, Qi X, Velarde-Miranda C, Plonczynski MW, Parker CR, Rainey W, Satoh F, Maekawa T, Nakamura Y, Sasano H, Gomez-Sanchez EP. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol 383: 111–117, 2014CrossRefPubMedPubMedCentral
7.
go back to reference Sasano H, Mason JI, Sasano N. Immunohistochemical study of cytochrome P-45017α in human adrenal disorders. Hum Pathol 20: 113–117, 1989CrossRefPubMed Sasano H, Mason JI, Sasano N. Immunohistochemical study of cytochrome P-45017α in human adrenal disorders. Hum Pathol 20: 113–117, 1989CrossRefPubMed
8.
go back to reference Sasano H, White PC, New MI, Sasano N. Immunohistochemical localization of cytochrome P450c21 in human adrenal cortex and its relation to endocrine function. Hum Pathol 19: 181–185, 1988CrossRefPubMed Sasano H, White PC, New MI, Sasano N. Immunohistochemical localization of cytochrome P450c21 in human adrenal cortex and its relation to endocrine function. Hum Pathol 19: 181–185, 1988CrossRefPubMed
9.
go back to reference Sasano H, Sasano N, Okamoto M. Immunohistochemical demonstration of cholesterol side-chain cleavage cytochrome P-450 in bovine and human adrenal. Pathol Res Pract 184: 337–342, 1989CrossRefPubMed Sasano H, Sasano N, Okamoto M. Immunohistochemical demonstration of cholesterol side-chain cleavage cytochrome P-450 in bovine and human adrenal. Pathol Res Pract 184: 337–342, 1989CrossRefPubMed
10.
go back to reference Sasano H, Sato F, Shizawa S, Nagura H, Coughtrie MW. Immunolocalization of dehydroepiandrosterone sulfotransferase in normal and pathologic human adrenal gland. Modern Pathol 8: 891–896, 1995 Sasano H, Sato F, Shizawa S, Nagura H, Coughtrie MW. Immunolocalization of dehydroepiandrosterone sulfotransferase in normal and pathologic human adrenal gland. Modern Pathol 8: 891–896, 1995
11.
go back to reference Weiss LM. Comparative histologic study of 43 metastasizing and non-metastasizing adrenocortical tumors. Am J Surg Pathol 8: 163–169, 1984CrossRefPubMed Weiss LM. Comparative histologic study of 43 metastasizing and non-metastasizing adrenocortical tumors. Am J Surg Pathol 8: 163–169, 1984CrossRefPubMed
12.
go back to reference Weiss LM, Medeiros LJ, Vickery AL: Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13: 202–206, 1989CrossRefPubMed Weiss LM, Medeiros LJ, Vickery AL: Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13: 202–206, 1989CrossRefPubMed
13.
go back to reference Mantero F, Arnaldi G. Management approaches to adrenal incidentalomas: a view from Ancona, Italy. Endocrinology and Metabolism Clinics of North America 29: 107–111, 2000CrossRefPubMed Mantero F, Arnaldi G. Management approaches to adrenal incidentalomas: a view from Ancona, Italy. Endocrinology and Metabolism Clinics of North America 29: 107–111, 2000CrossRefPubMed
14.
go back to reference L Barzon, N Sonino, F Fallo, G Palu, M Boscaro. Prevalence and natural history of adrenal incidentalomas. European Journal of Endocrinology 149: 273–285, 2003CrossRefPubMed L Barzon, N Sonino, F Fallo, G Palu, M Boscaro. Prevalence and natural history of adrenal incidentalomas. European Journal of Endocrinology 149: 273–285, 2003CrossRefPubMed
15.
go back to reference Komiya I, Takasu N, Aizawa T, Yamada T, Koizumi Y, Hashizume K, Ishihara M, Hiramatsu K, Ichikawa K, Katakura M, Kobayashi M, Yamauchi K, Yanagisawa K, Naka M, Miyamoto T. Black (or brown) adrenal cortical adenoma: its characteristic features on computed tomography and endocrine data. J Clin Endocrinol Metab 61: 711–717, 1985CrossRefPubMed Komiya I, Takasu N, Aizawa T, Yamada T, Koizumi Y, Hashizume K, Ishihara M, Hiramatsu K, Ichikawa K, Katakura M, Kobayashi M, Yamauchi K, Yanagisawa K, Naka M, Miyamoto T. Black (or brown) adrenal cortical adenoma: its characteristic features on computed tomography and endocrine data. J Clin Endocrinol Metab 61: 711–717, 1985CrossRefPubMed
16.
go back to reference Reschini E, Baldini M, Cantalamessa L. A black aderenocortical adenoma causing Cushing’s syndrome not imaged by radiocholesterol scintigraphy. Eur J Nucl Med 17: 185–18, 1990CrossRefPubMed Reschini E, Baldini M, Cantalamessa L. A black aderenocortical adenoma causing Cushing’s syndrome not imaged by radiocholesterol scintigraphy. Eur J Nucl Med 17: 185–18, 1990CrossRefPubMed
17.
go back to reference Kameyama K, Takami H. Pigmented granules in functional black adenoma of the adrenal gland: a histochemical and ultrastructural study. Endocr Pathol 10: 353–357, 1999CrossRefPubMed Kameyama K, Takami H. Pigmented granules in functional black adenoma of the adrenal gland: a histochemical and ultrastructural study. Endocr Pathol 10: 353–357, 1999CrossRefPubMed
18.
go back to reference Dixon RM, Lieberman LM, Gould HR, Hafez GR. [131I]Iodocholesterol scintiscan and a rare “functional” black adenoma of the adrenal cortex. J Nucl Med 24: 505–507, 1983PubMed Dixon RM, Lieberman LM, Gould HR, Hafez GR. [131I]Iodocholesterol scintiscan and a rare “functional” black adenoma of the adrenal cortex. J Nucl Med 24: 505–507, 1983PubMed
19.
go back to reference Nomura K, Saito H, Aiba M, Iihara M, Obara T, Takano K. Cushing’s syndrome due to bilateral adrenocortical adenomas with unique histological features. Endocr J 50: 155–162, 2003CrossRefPubMed Nomura K, Saito H, Aiba M, Iihara M, Obara T, Takano K. Cushing’s syndrome due to bilateral adrenocortical adenomas with unique histological features. Endocr J 50: 155–162, 2003CrossRefPubMed
20.
go back to reference Ambrosi B, Colombo P, Faglia G. Cushing’s syndrome due to a black adenoma of the adrenal gland: lack of tumour visualization by radiocholesterol scintigraphy. Eur J Nucl Med 21: 1367–1368, 1994CrossRefPubMed Ambrosi B, Colombo P, Faglia G. Cushing’s syndrome due to a black adenoma of the adrenal gland: lack of tumour visualization by radiocholesterol scintigraphy. Eur J Nucl Med 21: 1367–1368, 1994CrossRefPubMed
21.
go back to reference Mimou N, Sakato S, Nakabayashi H, Saito Z, Takeda R, Matsubara F. Cushing’s syndrome associated with bilateral adrenal adenomas. Acta Endocrinol (Copenh) 108: 245–254, 1985 Mimou N, Sakato S, Nakabayashi H, Saito Z, Takeda R, Matsubara F. Cushing’s syndrome associated with bilateral adrenal adenomas. Acta Endocrinol (Copenh) 108: 245–254, 1985
22.
go back to reference Inomoto C, Sato H, Kanai G, Hirukawa T, Shoji S, Terauchi T, Kajiwara H, Osamura RY. Black adrenal adenoma causing preclinical Cushing’s syndrome. Tokai J Exp Clin Med 35: 57–61, 2010PubMed Inomoto C, Sato H, Kanai G, Hirukawa T, Shoji S, Terauchi T, Kajiwara H, Osamura RY. Black adrenal adenoma causing preclinical Cushing’s syndrome. Tokai J Exp Clin Med 35: 57–61, 2010PubMed
23.
go back to reference Tokunaga H, Miyamura N, Sasaki K, Yoshizato K, Itasaka M, Nakamaru K, Suefuji M, Kawashima J, Matsumoto K, Sasano H, Araki E. Preclinical Cushing’s syndrome resulting from black adenoma. A case report. Horm Res 62: 60–66, 2004CrossRef Tokunaga H, Miyamura N, Sasaki K, Yoshizato K, Itasaka M, Nakamaru K, Suefuji M, Kawashima J, Matsumoto K, Sasano H, Araki E. Preclinical Cushing’s syndrome resulting from black adenoma. A case report. Horm Res 62: 60–66, 2004CrossRef
24.
go back to reference Odanaka M, Katabami T, Inoue M, Tadokoro M. Adrenal black adenoma associated with preclinical Cushing’s syndrome. Pathol Int 53: 796–799, 2003CrossRefPubMed Odanaka M, Katabami T, Inoue M, Tadokoro M. Adrenal black adenoma associated with preclinical Cushing’s syndrome. Pathol Int 53: 796–799, 2003CrossRefPubMed
25.
go back to reference Yin D. Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophore. Free Radic Biol Med 21: 871–888, 1996CrossRefPubMed Yin D. Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophore. Free Radic Biol Med 21: 871–888, 1996CrossRefPubMed
26.
Metadata
Title
A Case of Cushing’s Syndrome with Multiple Adrenocortical Adenomas Composed of Compact Cells and Clear Cells
Authors
Masahiro Asakawa
Takanobu Yoshimoto
Mitsutane Ota
Mitsuyuki Numasawa
Yuriko Sasahara
Takato Takeuchi
Yujiro Nakano
Norihiko Oohara
Masanori Murakami
Ryotaro Bouchi
Isao Minami
Kyoichiro Tsuchiya
Koshi Hashimoto
Hajime Izumiyama
Naoko Kawamura
Kazunori Kihara
Mariko Negi
Takumi Akashi
Yoshinobu Eishi
Hironobu Sasano
Yoshihiro Ogawa
Publication date
01-06-2016
Publisher
Springer US
Published in
Endocrine Pathology / Issue 2/2016
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-016-9423-x

Other articles of this Issue 2/2016

Endocrine Pathology 2/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.